These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

139 related articles for article (PubMed ID: 16312442)

  • 21. LY127935, a new beta-lactam antibiotic, versus Proteus, Klebsiella, Serratia, and Pseudomonas.
    Flournoy DJ; Perryman FA
    Antimicrob Agents Chemother; 1979 Nov; 16(5):641-3. PubMed ID: 526006
    [TBL] [Abstract][Full Text] [Related]  

  • 22. The in-vitro activity of cefotetan against Serratia spp. and Enterobacter spp. in comparison with other cephalosporins.
    Campello C; Stradoni R; Majori L
    J Antimicrob Chemother; 1983 Jan; 11 Suppl():87-93. PubMed ID: 6573328
    [No Abstract]   [Full Text] [Related]  

  • 23. [Statistical comparison of the bacteriostatic and bactericidal activity of beta-lactams and aminoglycosides on hospital bacteria strains (Pavia-Novara)].
    Farina C; Dos Santos C; Andreoni M; Picchini G; Concia E; Macchi V
    G Ital Chemioter; 1985; 32(1):245-53. PubMed ID: 3830786
    [No Abstract]   [Full Text] [Related]  

  • 24. [The mechanism of action of 2 major families of antibiotics: beta-lactams and aminoglycosides. Practical consequences].
    Michel-Briand Y
    Ann Anesthesiol Fr; 1979; 20(6-7):571-6. PubMed ID: 95083
    [No Abstract]   [Full Text] [Related]  

  • 25. In vitro activities of three carbapenems against recent bacterial isolates from severely ill patients at Swedish hospitals.
    Fraenkel CJ; Ullberg M; Bernander S; Ericson E; Larsson P; Rydberg J; Törnqvist E; Melhus A
    Scand J Infect Dis; 2006; 38(10):853-9. PubMed ID: 17008228
    [TBL] [Abstract][Full Text] [Related]  

  • 26. [Study of "in vitro" susceptibility of "Mycobacterium fortuitum" to aminoglycoside and beta-lactam antibiotics (author's transl)].
    Casal M; Rodriguez F
    Ann Microbiol (Paris); 1981; 132B(1):51-6. PubMed ID: 7305191
    [TBL] [Abstract][Full Text] [Related]  

  • 27. A Pseudomonas aeruginosa isolate producing the GES-5 extended-spectrum beta-lactamase.
    Wang C; Cai P; Chang D; Mi Z
    J Antimicrob Chemother; 2006 Jun; 57(6):1261-2. PubMed ID: 16617065
    [No Abstract]   [Full Text] [Related]  

  • 28. Plasmid-mediated 16S rRNA methylases among extended-spectrum-beta-lactamase-producing Salmonella enterica Senftenberg isolates from Algeria.
    Naas T; Bentchouala C; Lima S; Lezzar A; Smati F; Scheftel JM; Nordmann P
    J Antimicrob Chemother; 2009 Oct; 64(4):866-8. PubMed ID: 19700474
    [No Abstract]   [Full Text] [Related]  

  • 29. Dimeric aminoglycosides as antibiotics.
    Agnelli F; Sucheck SJ; Marby KA; Rabuka D; Yao SL; Sears PS; Liang FS; Wong CH
    Angew Chem Int Ed Engl; 2004 Mar; 43(12):1562-6. PubMed ID: 15022234
    [No Abstract]   [Full Text] [Related]  

  • 30. Outer membrane permeability of imipenem in comparison with other beta-lactam antibiotics.
    Hashizume T; Yamaguchi A; Sawai T
    J Antibiot (Tokyo); 1986 Jan; 39(1):153-6. PubMed ID: 3512504
    [No Abstract]   [Full Text] [Related]  

  • 31. High-level aminoglycoside resistance and beta-lactamase production in enterococci at a tertiary care hospital in India.
    Agarwal J; Kalyan R; Singh M
    Jpn J Infect Dis; 2009 Mar; 62(2):158-9. PubMed ID: 19305061
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Extended spectrum AmpC and metallo-beta-lactamases in Serratia and Citrobacter spp. in a disc approximation assay.
    Rizvi M; Fatima N; Rashid M; Shukla I; Malik A; Usman A; Siddiqui S
    J Infect Dev Ctries; 2009 May; 3(4):285-94. PubMed ID: 19759492
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Extended spectrum AmpC and metallo-beta-lactamases in Serratia and Citrobacter spp. in a disc approximation assay.
    Rizvi M; Fatima N; Rashid M; Shukla I; Malik A; Usman A; Siddiqui S
    J Infect Dev Ctries; 2009 Apr; 3(3):177-86. PubMed ID: 19759472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Pseudomonas aeruginosa and beta-lactam antibiotics at the time of Europe].
    Cavallo JD; Mérens A
    Pathol Biol (Paris); 2008; 56(7-8):435-8. PubMed ID: 19019568
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Metallo-beta-lactamase-producing Pseudomonas aeruginosa isolates in Tunisia.
    Mansour W; Poirel L; Bettaieb D; Bouallegue O; Boujaafar N; Nordmann P
    Diagn Microbiol Infect Dis; 2009 Aug; 64(4):458-61. PubMed ID: 19631102
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Aminoglycoside/beta-lactam combinations in clinical practice.
    Leibovici L; Paul M
    J Antimicrob Chemother; 2007 Nov; 60(5):911-2. PubMed ID: 17890282
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Survey of resistance of Pseudomonas aeruginosa to aminoglycosides and beta-lactam antibiotics in the Netherlands.
    De Neeling AJ; Rutgers A; Schot CS; Van Klingeren B
    J Antimicrob Chemother; 1987 May; 19(5):703-6. PubMed ID: 3112098
    [No Abstract]   [Full Text] [Related]  

  • 38. Bactericidal effect of combinations of antibiotics on Klebsiella-Enterobacter-Serratia.
    Luboshitzky R; Sacks T; Michel J
    Chemotherapy; 1973; 19(6):354-66. PubMed ID: 4794085
    [No Abstract]   [Full Text] [Related]  

  • 39. Evolution of extended-spectrum beta-lactamases in a MutS-deficient Pseudomonas aeruginosa hypermutator.
    Driffield KL; Bostock JM; Miller K; O'neill AJ; Hobbs JK; Chopra I
    J Antimicrob Chemother; 2006 Oct; 58(4):905-7. PubMed ID: 16901912
    [No Abstract]   [Full Text] [Related]  

  • 40. Aminoglycosides and beta-lactams. Different possible kind of interaction during the time between drugs and microorganisms.
    Carazzone M; Martinetto P; Malcangi A
    G Ital Chemioter; 1987; 34(1-3):29-39. PubMed ID: 3332869
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.